Navigation Links
Race Based Genome Project Launched By Mexico

Mexico has launched a race based genome project to determine if a genetic basis exists for its growing health crisis. The goal is to clean insights into genetic differences, believed to be unique// to its population, which may play a key role in chronic diseases like asthma, diabetes and hypertension.

Applied Biosystems (ABI), IBM Health care and Affymetrix with assist the government in sequencing, genotyping and data analysis. The Instituto Nacional de Medicina Genomica (National Genomic Medicine Institute of Mexico) or INMGEN will manage the resulting ‘Mexican HapMap’.

According to Gerardo Jimenez, director of INMEGEN and the new collaboration, INMEGEN will begin by sampling individuals in six remote regions of Mexico to construct a consensus genetic map that fits the entire Mexican mestizo population, a mixture of Europeans and Indians. The first objective is to determine if every block of nucleic acid sequence will be alike for all the Mexican groups. “My own prediction, “says Jimenez” is that we are not going to find huge differences.”

INMEGEN will release newly mined genomic data into the public domain as fast a technology allows, but Jimenez is quick to point out that the measure of the project’s success is not the science, but rather the medicines that come out of it. The close economic and political ties between the two nations lend a degree of legitimacy and accountability to the project, and Jimenez, who is an experienced genomics researcher, is well aware of the social implications of genomics analysis.

INMEGEN’s research will be subject to oversight as well as review by a panel comprising the country’s leading academic bioethics. The genomics project will be managed according to US National Institutes of Health ethical standards. Despite this promising start, some warn that even seemingly airtight laws and scientists best intentions cannot ensure against abuses.

(Source: Nature Biotechology)
'"/>




Page: 1

Related medicine news :

1. Steps To Improve Quality Of Plant-Based Drugs
2. Cancer hazard Found With Animal-Based Nutrients
3. Prime Minister Manmohan Against Incentive-Based Population Control
4. New Oat And Soy-Based Fat Replacer Launched
5. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
6. Childhood Asthma Can Be Kept Under Control By Cost-Effective Home Based Interventions
7. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
8. Web Based Psychotherapy for Depression
9. Relief For British MS Patients: Cannabis-Based Oral Spray
10. Child-friendly initiative For Lead-Based Paint Work: EPA, USA
11. Indian Hospital Recruits UK Based Doctors

Post Your Comments:
(Date:11/25/2009)...RSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anartic...DrugEvaluationandResearch,titled"ADifficultBalance...Nov.26,2009issueofTheNewEnglandJournalofMedicine. ...0090824/FDALOGO ) ,, Inthearticle,Woodcockdiscu...edicationforthosewhoneeditandmanagingtherisksposed...
(Date:11/25/2009)...ANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMa... Spare the Air Alert forThursday,Novem...soranyothersolidfuel,bothindoorsandoutdoors. ,,...litytomorrow,"saidJackBroadbent,executiveofficerof...ctthehealthoftheirneighborsandfellowcommunitymembe...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)...low-up period was too short to draw definite concl.... 25 (HealthDay News) -- In diabetic patients with... difference in outcomes at one year whether patien...ting, British researchers report. , Bypass surg...atients with coronary artery disease. However, les...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ing the chances,of women faced with an aggressive ...nflammatory breast cancer spreads quickly and can ...rodeoxyglucose positron emission,tomography combin...day at the annual meeting of the Radiological Soci...
...rials Worldwide,Inc. announced today that their pe...uit, which is related to Datasci,s U.S. Patent Num...ion of clinical trial data. Under the,terms of the...e granted a license to etrials," said Dr. Marc,Koz...
...VEREST Pivotal Study and Begin ...nue to Build on Initial Data Showing Durability, E...or Percutaneous Repair of Mitr...lves,announced today that it had successfully comp...
...e agency looking into Tamiflu; Relenza also under ...News) -- A U.S. Food and Drug Administration panel...eling for the prescription flu drug Tamiflu (oselt...idering label changes to Tamiflu and another flu d...
...You Measuring the Wrong Things?, NEW YORK and LON... ensure maximum return on investment, sales force ...lobal pharmaceutical industry. Reports,have shown ...address this alarming issue, Eularis announces tod...
..., the leading,provider of databases, software and ...Elan Pharmaceuticals has joined the MetaTox Consor...will be focused on developing,systems biology tool...overy(TM) platform with toxicity ontologies,develo...
Other Medicine News:Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 2Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 3Health News:Evalve(R) Completes $60 Million Series D Financing 2Health News:Evalve(R) Completes $60 Million Series D Financing 3Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 2Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 3Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 2Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 3
(Date:11/24/2009)...ewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkShee...zationandDisclosureStatementtoday,November24,2009,...Delaware.AhearingtoconsiderapprovaloftheDisclosure...hthehearingontheconfirmationofthePlanscheduledforJ...allclaimsinfull.ThePlanisexpected,ifapproved,toall...
(Date:11/24/2009)...wire/--Inadditiontofamily,friendsandhealth,cancers...rThanksgivinggratitudelist. ,, "Theyheardthefac...dofMonday,sverdictstotaling$103millionindamagesaga...000womennationwidewhohavesuedWyethandPfizerpharmac...Prempro.Wisneskiandtheothervictimsofhormonetherapy...
(Date:11/24/2009)...ewswire/--ZargisMedicalCorp.,asubsidiaryofSpeedusC...eResearch(NYSE: SI ),todayannouncedthatitsZargisCa...deofCBS, TheEarlyShow duringasegmentinwhichMarkJan...vewinningproductsfromthepublication,s2009"BestofWh...edtelevisionmorningnewstalkshowbroadcastbyCBSfromN...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4Cell Therapeutics Inc 28CTI 29 to Report Third Quarter Financial Results on November 5 60483 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: